Indivior Pharmaceuticals Inc (INDV) Stock Competitors & Peer Comparison
See (INDV) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDV | $34.88 | -3.16% | 4.4B | 17.89 | $1.95 | N/A |
| TAK | $15.19 | -4.82% | 48B | 39.99 | $0.38 | +4.06% |
| TEVA | $34.64 | -1.93% | 40.3B | 25.85 | $1.34 | N/A |
| HLN | $8.84 | -2.43% | 39.2B | 17.65 | $0.50 | +2.17% |
| VTRS | $15.81 | -2.77% | 18.4B | -52.70 | -$0.30 | +2.99% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| RGC | $24.17 | +1.13% | 12B | -2417.00 | -$0.01 | N/A |
| ELAN | $23.67 | -0.75% | 11.8B | -47.38 | -$0.50 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| RDY | $13.26 | -2.71% | 11B | 25.51 | $0.52 | +0.69% |
Stock Comparison
INDV vs TAK Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TAK has a market cap of 48B. Regarding current trading prices, INDV is priced at $34.88, while TAK trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TAK's P/E ratio is 39.99. In terms of profitability, INDV's ROE is -1.42%, compared to TAK's ROE of +0.03%. Regarding short-term risk, INDV is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check TAK's competition here
INDV vs TEVA Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TEVA has a market cap of 40.3B. Regarding current trading prices, INDV is priced at $34.88, while TEVA trades at $34.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TEVA's P/E ratio is 25.85. In terms of profitability, INDV's ROE is -1.42%, compared to TEVA's ROE of +0.21%. Regarding short-term risk, INDV is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check TEVA's competition here
INDV vs HLN Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, HLN has a market cap of 39.2B. Regarding current trading prices, INDV is priced at $34.88, while HLN trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas HLN's P/E ratio is 17.65. In terms of profitability, INDV's ROE is -1.42%, compared to HLN's ROE of +0.17%. Regarding short-term risk, INDV is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check HLN's competition here
INDV vs VTRS Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, VTRS has a market cap of 18.4B. Regarding current trading prices, INDV is priced at $34.88, while VTRS trades at $15.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas VTRS's P/E ratio is -52.70. In terms of profitability, INDV's ROE is -1.42%, compared to VTRS's ROE of -0.02%. Regarding short-term risk, INDV is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check VTRS's competition here
INDV vs ITCI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, INDV is priced at $34.88, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ITCI's P/E ratio is -180.64. In terms of profitability, INDV's ROE is -1.42%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, INDV is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check ITCI's competition here
INDV vs RGC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, RGC has a market cap of 12B. Regarding current trading prices, INDV is priced at $34.88, while RGC trades at $24.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas RGC's P/E ratio is -2417.00. In terms of profitability, INDV's ROE is -1.42%, compared to RGC's ROE of -2.32%. Regarding short-term risk, INDV is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check RGC's competition here
INDV vs ELAN Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ELAN has a market cap of 11.8B. Regarding current trading prices, INDV is priced at $34.88, while ELAN trades at $23.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ELAN's P/E ratio is -47.38. In terms of profitability, INDV's ROE is -1.42%, compared to ELAN's ROE of -0.04%. Regarding short-term risk, INDV is less volatile compared to ELAN. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ELAN's competition here
INDV vs CTLT Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, INDV is priced at $34.88, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CTLT's P/E ratio is -27.84. In terms of profitability, INDV's ROE is -1.42%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, INDV is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check CTLT's competition here
INDV vs RDY Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, RDY has a market cap of 11B. Regarding current trading prices, INDV is priced at $34.88, while RDY trades at $13.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas RDY's P/E ratio is 25.51. In terms of profitability, INDV's ROE is -1.42%, compared to RDY's ROE of +0.12%. Regarding short-term risk, INDV is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check RDY's competition here
INDV vs LNTH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, LNTH has a market cap of 6.3B. Regarding current trading prices, INDV is priced at $34.88, while LNTH trades at $97.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas LNTH's P/E ratio is 23.18. In terms of profitability, INDV's ROE is -1.42%, compared to LNTH's ROE of +0.24%. Regarding short-term risk, INDV is less volatile compared to LNTH. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check LNTH's competition here
INDV vs AMRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AMRX has a market cap of 4.1B. Regarding current trading prices, INDV is priced at $34.88, while AMRX trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AMRX's P/E ratio is 34.86. In terms of profitability, INDV's ROE is -1.42%, compared to AMRX's ROE of -1.45%. Regarding short-term risk, INDV is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check AMRX's competition here
INDV vs SUPN Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SUPN has a market cap of 2.6B. Regarding current trading prices, INDV is priced at $34.88, while SUPN trades at $44.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SUPN's P/E ratio is -87.76. In terms of profitability, INDV's ROE is -1.42%, compared to SUPN's ROE of -0.03%. Regarding short-term risk, INDV is less volatile compared to SUPN. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check SUPN's competition here
INDV vs DCPH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, INDV is priced at $34.88, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas DCPH's P/E ratio is -11.58. In terms of profitability, INDV's ROE is -1.42%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, INDV is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check DCPH's competition here
INDV vs AVDL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, INDV is priced at $34.88, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, INDV's ROE is -1.42%, compared to AVDL's ROE of -0.00%. Regarding short-term risk, INDV is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check AVDL's competition here
INDV vs HCM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, HCM has a market cap of 2B. Regarding current trading prices, INDV is priced at $34.88, while HCM trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas HCM's P/E ratio is 4.30. In terms of profitability, INDV's ROE is -1.42%, compared to HCM's ROE of +0.41%. Regarding short-term risk, INDV is less volatile compared to HCM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check HCM's competition here
INDV vs BHC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, BHC has a market cap of 2B. Regarding current trading prices, INDV is priced at $34.88, while BHC trades at $5.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas BHC's P/E ratio is -1.64. In terms of profitability, INDV's ROE is -1.42%, compared to BHC's ROE of +1.21%. Regarding short-term risk, INDV is less volatile compared to BHC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check BHC's competition here
INDV vs EMBCV Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, INDV is priced at $34.88, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EMBCV's P/E ratio is N/A. In terms of profitability, INDV's ROE is -1.42%, compared to EMBCV's ROE of -0.23%. Regarding short-term risk, INDV is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check EMBCV's competition here
INDV vs DVAX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, INDV is priced at $34.88, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas DVAX's P/E ratio is -41.89. In terms of profitability, INDV's ROE is -1.42%, compared to DVAX's ROE of -0.08%. Regarding short-term risk, INDV is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check DVAX's competition here
INDV vs ANIP Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, INDV is priced at $34.88, while ANIP trades at $76.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ANIP's P/E ratio is 19.62. In terms of profitability, INDV's ROE is -1.42%, compared to ANIP's ROE of +0.17%. Regarding short-term risk, INDV is less volatile compared to ANIP. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ANIP's competition here
INDV vs TARO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, INDV is priced at $34.88, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TARO's P/E ratio is 30.05. In terms of profitability, INDV's ROE is -1.42%, compared to TARO's ROE of +0.03%. Regarding short-term risk, INDV is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check TARO's competition here
INDV vs PRGO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PRGO has a market cap of 1.5B. Regarding current trading prices, INDV is priced at $34.88, while PRGO trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PRGO's P/E ratio is -0.83. In terms of profitability, INDV's ROE is -1.42%, compared to PRGO's ROE of -0.51%. Regarding short-term risk, INDV is less volatile compared to PRGO. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check PRGO's competition here
INDV vs HROW Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, HROW has a market cap of 1.3B. Regarding current trading prices, INDV is priced at $34.88, while HROW trades at $34.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas HROW's P/E ratio is -89.76. In terms of profitability, INDV's ROE is -1.42%, compared to HROW's ROE of -0.34%. Regarding short-term risk, INDV is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check HROW's competition here
INDV vs PAHC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PAHC has a market cap of 1.2B. Regarding current trading prices, INDV is priced at $34.88, while PAHC trades at $29.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PAHC's P/E ratio is 12.82. In terms of profitability, INDV's ROE is -1.42%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, INDV is less volatile compared to PAHC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check PAHC's competition here
INDV vs EVO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EVO has a market cap of 1.1B. Regarding current trading prices, INDV is priced at $34.88, while EVO trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EVO's P/E ratio is -4.87. In terms of profitability, INDV's ROE is -1.42%, compared to EVO's ROE of -0.24%. Regarding short-term risk, INDV is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check EVO's competition here
INDV vs CRON Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CRON has a market cap of 1.1B. Regarding current trading prices, INDV is priced at $34.88, while CRON trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CRON's P/E ratio is -141.00. In terms of profitability, INDV's ROE is -1.42%, compared to CRON's ROE of -0.00%. Regarding short-term risk, INDV is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check CRON's competition here
INDV vs COLL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, COLL has a market cap of 1B. Regarding current trading prices, INDV is priced at $34.88, while COLL trades at $31.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas COLL's P/E ratio is 15.43. In terms of profitability, INDV's ROE is -1.42%, compared to COLL's ROE of +0.27%. Regarding short-term risk, INDV is less volatile compared to COLL. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check COLL's competition here
INDV vs ALVO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ALVO has a market cap of 1B. Regarding current trading prices, INDV is priced at $34.88, while ALVO trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ALVO's P/E ratio is 32.20. In terms of profitability, INDV's ROE is -1.42%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, INDV is less volatile compared to ALVO. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ALVO's competition here
INDV vs PETQ Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, INDV is priced at $34.88, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PETQ's P/E ratio is 83.73. In terms of profitability, INDV's ROE is -1.42%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, INDV is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check PETQ's competition here
INDV vs PCRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PCRX has a market cap of 903.1M. Regarding current trading prices, INDV is priced at $34.88, while PCRX trades at $22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PCRX's P/E ratio is 176.62. In terms of profitability, INDV's ROE is -1.42%, compared to PCRX's ROE of +0.01%. Regarding short-term risk, INDV is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check PCRX's competition here
INDV vs AMPH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AMPH has a market cap of 812.2M. Regarding current trading prices, INDV is priced at $34.88, while AMPH trades at $18.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AMPH's P/E ratio is 11.10. In terms of profitability, INDV's ROE is -1.42%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, INDV is less volatile compared to AMPH. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check AMPH's competition here
INDV vs TLRY Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TLRY has a market cap of 656.6M. Regarding current trading prices, INDV is priced at $34.88, while TLRY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TLRY's P/E ratio is -0.38. In terms of profitability, INDV's ROE is -1.42%, compared to TLRY's ROE of -0.93%. Regarding short-term risk, INDV is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check TLRY's competition here
INDV vs BDSI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, INDV is priced at $34.88, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas BDSI's P/E ratio is 6.82. In terms of profitability, INDV's ROE is -1.42%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, INDV is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check BDSI's competition here
INDV vs IRWD Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, IRWD has a market cap of 569.6M. Regarding current trading prices, INDV is priced at $34.88, while IRWD trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas IRWD's P/E ratio is 5.58. In terms of profitability, INDV's ROE is -1.42%, compared to IRWD's ROE of -0.39%. Regarding short-term risk, INDV is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check IRWD's competition here
INDV vs CGC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CGC has a market cap of 459.9M. Regarding current trading prices, INDV is priced at $34.88, while CGC trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CGC's P/E ratio is -0.81. In terms of profitability, INDV's ROE is -1.42%, compared to CGC's ROE of -0.51%. Regarding short-term risk, INDV is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check CGC's competition here
INDV vs KMDA Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, KMDA has a market cap of 444.2M. Regarding current trading prices, INDV is priced at $34.88, while KMDA trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas KMDA's P/E ratio is 22.00. In terms of profitability, INDV's ROE is -1.42%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, INDV is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check KMDA's competition here
INDV vs EOLS Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EOLS has a market cap of 429.4M. Regarding current trading prices, INDV is priced at $34.88, while EOLS trades at $6.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EOLS's P/E ratio is -9.88. In terms of profitability, INDV's ROE is -1.42%, compared to EOLS's ROE of +1.75%. Regarding short-term risk, INDV is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check EOLS's competition here
INDV vs AQST Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AQST has a market cap of 397.2M. Regarding current trading prices, INDV is priced at $34.88, while AQST trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AQST's P/E ratio is -6.56. In terms of profitability, INDV's ROE is -1.42%, compared to AQST's ROE of +1.91%. Regarding short-term risk, INDV is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check AQST's competition here
INDV vs SNDL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SNDL has a market cap of 378.4M. Regarding current trading prices, INDV is priced at $34.88, while SNDL trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SNDL's P/E ratio is -48.67. In terms of profitability, INDV's ROE is -1.42%, compared to SNDL's ROE of -0.01%. Regarding short-term risk, INDV is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check SNDL's competition here
INDV vs SIGA Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SIGA has a market cap of 318.5M. Regarding current trading prices, INDV is priced at $34.88, while SIGA trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SIGA's P/E ratio is 15.86. In terms of profitability, INDV's ROE is -1.42%, compared to SIGA's ROE of +0.11%. Regarding short-term risk, INDV is less volatile compared to SIGA. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check SIGA's competition here
INDV vs ORGO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ORGO has a market cap of 303.7M. Regarding current trading prices, INDV is priced at $34.88, while ORGO trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ORGO's P/E ratio is -19.67. In terms of profitability, INDV's ROE is -1.42%, compared to ORGO's ROE of -0.00%. Regarding short-term risk, INDV is less volatile compared to ORGO. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ORGO's competition here
INDV vs ALIM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, INDV is priced at $34.88, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ALIM's P/E ratio is 5.28. In terms of profitability, INDV's ROE is -1.42%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, INDV is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check ALIM's competition here
INDV vs TKNO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TKNO has a market cap of 287.9M. Regarding current trading prices, INDV is priced at $34.88, while TKNO trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TKNO's P/E ratio is -17.32. In terms of profitability, INDV's ROE is -1.42%, compared to TKNO's ROE of -0.24%. Regarding short-term risk, INDV is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check TKNO's competition here
INDV vs LNDC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, INDV is priced at $34.88, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas LNDC's P/E ratio is -4.04. In terms of profitability, INDV's ROE is -1.42%, compared to LNDC's ROE of -9.05%. Regarding short-term risk, INDV is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check LNDC's competition here
INDV vs TYHT Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, INDV is priced at $34.88, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TYHT's P/E ratio is -1.61. In terms of profitability, INDV's ROE is -1.42%, compared to TYHT's ROE of -0.65%. Regarding short-term risk, INDV is less volatile compared to TYHT. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check TYHT's competition here
INDV vs ACB Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ACB has a market cap of 206.4M. Regarding current trading prices, INDV is priced at $34.88, while ACB trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ACB's P/E ratio is -3.37. In terms of profitability, INDV's ROE is -1.42%, compared to ACB's ROE of -0.08%. Regarding short-term risk, INDV is less volatile compared to ACB. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ACB's competition here
INDV vs EMBC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EMBC has a market cap of 195.2M. Regarding current trading prices, INDV is priced at $34.88, while EMBC trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EMBC's P/E ratio is 1.74. In terms of profitability, INDV's ROE is -1.42%, compared to EMBC's ROE of -0.17%. Regarding short-term risk, INDV is less volatile compared to EMBC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check EMBC's competition here
INDV vs LFCR Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, LFCR has a market cap of 181.9M. Regarding current trading prices, INDV is priced at $34.88, while LFCR trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas LFCR's P/E ratio is -3.82. In terms of profitability, INDV's ROE is -1.42%, compared to LFCR's ROE of -1.47%. Regarding short-term risk, INDV is less volatile compared to LFCR. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check LFCR's competition here
INDV vs REPH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, INDV is priced at $34.88, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas REPH's P/E ratio is -8.04. In terms of profitability, INDV's ROE is -1.42%, compared to REPH's ROE of -0.22%. Regarding short-term risk, INDV is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check REPH's competition here
INDV vs DERM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, DERM has a market cap of 167.6M. Regarding current trading prices, INDV is priced at $34.88, while DERM trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas DERM's P/E ratio is -16.46. In terms of profitability, INDV's ROE is -1.42%, compared to DERM's ROE of -0.36%. Regarding short-term risk, INDV is less volatile compared to DERM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check DERM's competition here
INDV vs OGI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, OGI has a market cap of 159.1M. Regarding current trading prices, INDV is priced at $34.88, while OGI trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas OGI's P/E ratio is -7.53. In terms of profitability, INDV's ROE is -1.42%, compared to OGI's ROE of -0.07%. Regarding short-term risk, INDV is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check OGI's competition here
INDV vs THTX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, INDV is priced at $34.88, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas THTX's P/E ratio is -17.84. In terms of profitability, INDV's ROE is -1.42%, compared to THTX's ROE of +0.47%. Regarding short-term risk, INDV is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check THTX's competition here
INDV vs ASRT Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ASRT has a market cap of 151.4M. Regarding current trading prices, INDV is priced at $34.88, while ASRT trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ASRT's P/E ratio is -4.22. In terms of profitability, INDV's ROE is -1.42%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, INDV is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check ASRT's competition here
INDV vs CRDL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CRDL has a market cap of 136.5M. Regarding current trading prices, INDV is priced at $34.88, while CRDL trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CRDL's P/E ratio is -4.36. In terms of profitability, INDV's ROE is -1.42%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, INDV is less volatile compared to CRDL. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check CRDL's competition here
INDV vs SCTL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, INDV is priced at $34.88, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SCTL's P/E ratio is -7.86. In terms of profitability, INDV's ROE is -1.42%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, INDV is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check SCTL's competition here
INDV vs PROC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, INDV is priced at $34.88, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PROC's P/E ratio is 1.53. In terms of profitability, INDV's ROE is -1.42%, compared to PROC's ROE of -2.22%. Regarding short-term risk, INDV is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check PROC's competition here
INDV vs OPTN Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, INDV is priced at $34.88, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas OPTN's P/E ratio is -4.42. In terms of profitability, INDV's ROE is -1.42%, compared to OPTN's ROE of +0.45%. Regarding short-term risk, INDV is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check OPTN's competition here
INDV vs ZOM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, INDV is priced at $34.88, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ZOM's P/E ratio is -1.62. In terms of profitability, INDV's ROE is -1.42%, compared to ZOM's ROE of -0.19%. Regarding short-term risk, INDV is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ZOM's competition here
INDV vs GRVI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, INDV is priced at $34.88, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas GRVI's P/E ratio is 26.05. In terms of profitability, INDV's ROE is -1.42%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, INDV is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check GRVI's competition here
INDV vs CPIX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CPIX has a market cap of 85.4M. Regarding current trading prices, INDV is priced at $34.88, while CPIX trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CPIX's P/E ratio is -11.63. In terms of profitability, INDV's ROE is -1.42%, compared to CPIX's ROE of -0.29%. Regarding short-term risk, INDV is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check CPIX's competition here
INDV vs ALVOW Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ALVOW has a market cap of 78M. Regarding current trading prices, INDV is priced at $34.88, while ALVOW trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ALVOW's P/E ratio is N/A. In terms of profitability, INDV's ROE is -1.42%, compared to ALVOW's ROE of +0.35%. Regarding short-term risk, INDV is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ALVOW's competition here
INDV vs ZYNE Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, INDV is priced at $34.88, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, INDV's ROE is -1.42%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, INDV is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ZYNE's competition here
INDV vs SSIC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, INDV is priced at $34.88, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SSIC's P/E ratio is 11.93. In terms of profitability, INDV's ROE is -1.42%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, INDV is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check SSIC's competition here
INDV vs BGM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, BGM has a market cap of 64.1M. Regarding current trading prices, INDV is priced at $34.88, while BGM trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas BGM's P/E ratio is -1.10. In terms of profitability, INDV's ROE is -1.42%, compared to BGM's ROE of -0.03%. Regarding short-term risk, INDV is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check BGM's competition here
INDV vs VLNS Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, INDV is priced at $34.88, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas VLNS's P/E ratio is -1.03. In terms of profitability, INDV's ROE is -1.42%, compared to VLNS's ROE of N/A. Regarding short-term risk, INDV is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check VLNS's competition here
INDV vs INCR Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, INCR has a market cap of 59.6M. Regarding current trading prices, INDV is priced at $34.88, while INCR trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas INCR's P/E ratio is -4.74. In terms of profitability, INDV's ROE is -1.42%, compared to INCR's ROE of -0.09%. Regarding short-term risk, INDV is less volatile compared to INCR. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check INCR's competition here
INDV vs DRRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, INDV is priced at $34.88, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas DRRX's P/E ratio is -4.44. In terms of profitability, INDV's ROE is -1.42%, compared to DRRX's ROE of +0.13%. Regarding short-term risk, INDV is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check DRRX's competition here
INDV vs JUPW Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, INDV is priced at $34.88, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas JUPW's P/E ratio is -2.41. In terms of profitability, INDV's ROE is -1.42%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, INDV is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check JUPW's competition here
INDV vs QLI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, INDV is priced at $34.88, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas QLI's P/E ratio is -4.92. In terms of profitability, INDV's ROE is -1.42%, compared to QLI's ROE of -0.16%. Regarding short-term risk, INDV is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check QLI's competition here
INDV vs ZYBT Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ZYBT has a market cap of 38.2M. Regarding current trading prices, INDV is priced at $34.88, while ZYBT trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ZYBT's P/E ratio is -3.67. In terms of profitability, INDV's ROE is -1.42%, compared to ZYBT's ROE of -0.26%. Regarding short-term risk, INDV is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ZYBT's competition here
INDV vs IXHL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, IXHL has a market cap of 37.3M. Regarding current trading prices, INDV is priced at $34.88, while IXHL trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas IXHL's P/E ratio is -0.20. In terms of profitability, INDV's ROE is -1.42%, compared to IXHL's ROE of -1.23%. Regarding short-term risk, INDV is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check IXHL's competition here
INDV vs SCYX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SCYX has a market cap of 33.5M. Regarding current trading prices, INDV is priced at $34.88, while SCYX trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SCYX's P/E ratio is -1.39. In terms of profitability, INDV's ROE is -1.42%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, INDV is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check SCYX's competition here
INDV vs HEXO Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, INDV is priced at $34.88, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas HEXO's P/E ratio is -0.26. In terms of profitability, INDV's ROE is -1.42%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, INDV is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check HEXO's competition here
INDV vs RMTI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, RMTI has a market cap of 28.3M. Regarding current trading prices, INDV is priced at $34.88, while RMTI trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas RMTI's P/E ratio is -4.79. In terms of profitability, INDV's ROE is -1.42%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, INDV is less volatile compared to RMTI. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check RMTI's competition here
INDV vs TXMD Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TXMD has a market cap of 24.5M. Regarding current trading prices, INDV is priced at $34.88, while TXMD trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TXMD's P/E ratio is 212.00. In terms of profitability, INDV's ROE is -1.42%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, INDV is less volatile compared to TXMD. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check TXMD's competition here
INDV vs CYTH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, INDV is priced at $34.88, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CYTH's P/E ratio is -0.80. In terms of profitability, INDV's ROE is -1.42%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, INDV is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check CYTH's competition here
INDV vs QNTM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, QNTM has a market cap of 23.6M. Regarding current trading prices, INDV is priced at $34.88, while QNTM trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas QNTM's P/E ratio is -0.68. In terms of profitability, INDV's ROE is -1.42%, compared to QNTM's ROE of -6.22%. Regarding short-term risk, INDV is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check QNTM's competition here
INDV vs EVOK Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, INDV is priced at $34.88, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EVOK's P/E ratio is -7.97. In terms of profitability, INDV's ROE is -1.42%, compared to EVOK's ROE of -1.01%. Regarding short-term risk, INDV is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check EVOK's competition here
INDV vs OPTH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, OPTH has a market cap of 18.2M. Regarding current trading prices, INDV is priced at $34.88, while OPTH trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas OPTH's P/E ratio is -5.22. In terms of profitability, INDV's ROE is -1.42%, compared to OPTH's ROE of -0.57%. Regarding short-term risk, INDV is less volatile compared to OPTH. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check OPTH's competition here
INDV vs AYTU Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AYTU has a market cap of 17.4M. Regarding current trading prices, INDV is priced at $34.88, while AYTU trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AYTU's P/E ratio is -0.47. In terms of profitability, INDV's ROE is -1.42%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, INDV is less volatile compared to AYTU. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check AYTU's competition here
INDV vs TLPH Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, TLPH has a market cap of 16.3M. Regarding current trading prices, INDV is priced at $34.88, while TLPH trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas TLPH's P/E ratio is -2.83. In terms of profitability, INDV's ROE is -1.42%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, INDV is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check TLPH's competition here
INDV vs ACRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, INDV is priced at $34.88, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ACRX's P/E ratio is -0.31. In terms of profitability, INDV's ROE is -1.42%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, INDV is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ACRX's competition here
INDV vs COSM Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, COSM has a market cap of 13.7M. Regarding current trading prices, INDV is priced at $34.88, while COSM trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas COSM's P/E ratio is -0.38. In terms of profitability, INDV's ROE is -1.42%, compared to COSM's ROE of -0.96%. Regarding short-term risk, INDV is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check COSM's competition here
INDV vs BFRI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, BFRI has a market cap of 12.2M. Regarding current trading prices, INDV is priced at $34.88, while BFRI trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas BFRI's P/E ratio is -0.97. In terms of profitability, INDV's ROE is -1.42%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, INDV is less volatile compared to BFRI. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check BFRI's competition here
INDV vs AGRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, INDV is priced at $34.88, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas AGRX's P/E ratio is -0.89. In terms of profitability, INDV's ROE is -1.42%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, INDV is less volatile compared to AGRX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check AGRX's competition here
INDV vs YCBD Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, YCBD has a market cap of 8.3M. Regarding current trading prices, INDV is priced at $34.88, while YCBD trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas YCBD's P/E ratio is 0.32. In terms of profitability, INDV's ROE is -1.42%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, INDV is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check YCBD's competition here
INDV vs NLTX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, INDV is priced at $34.88, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas NLTX's P/E ratio is -0.28. In terms of profitability, INDV's ROE is -1.42%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, INDV is less volatile compared to NLTX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check NLTX's competition here
INDV vs LCI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, INDV is priced at $34.88, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas LCI's P/E ratio is -0.04. In terms of profitability, INDV's ROE is -1.42%, compared to LCI's ROE of +1.66%. Regarding short-term risk, INDV is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check LCI's competition here
INDV vs BGXX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, INDV is priced at $34.88, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas BGXX's P/E ratio is -0.76. In terms of profitability, INDV's ROE is -1.42%, compared to BGXX's ROE of -1.16%. Regarding short-term risk, INDV is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check BGXX's competition here
INDV vs ADMP Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, INDV is priced at $34.88, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ADMP's P/E ratio is -0.08. In terms of profitability, INDV's ROE is -1.42%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, INDV is less volatile compared to ADMP. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check ADMP's competition here
INDV vs EGRX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, EGRX has a market cap of 6.1M. Regarding current trading prices, INDV is priced at $34.88, while EGRX trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas EGRX's P/E ratio is 6.57. In terms of profitability, INDV's ROE is -1.42%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, INDV is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check EGRX's competition here
INDV vs MNK Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, INDV is priced at $34.88, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas MNK's P/E ratio is -0.44. In terms of profitability, INDV's ROE is -1.42%, compared to MNK's ROE of -0.26%. Regarding short-term risk, INDV is less volatile compared to MNK. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check MNK's competition here
INDV vs GELS Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, GELS has a market cap of 4.4M. Regarding current trading prices, INDV is priced at $34.88, while GELS trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas GELS's P/E ratio is -0.95. In terms of profitability, INDV's ROE is -1.42%, compared to GELS's ROE of -0.43%. Regarding short-term risk, INDV is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check GELS's competition here
INDV vs FLGC Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, INDV is priced at $34.88, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas FLGC's P/E ratio is -0.19. In terms of profitability, INDV's ROE is -1.42%, compared to FLGC's ROE of -0.08%. Regarding short-term risk, INDV is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check FLGC's competition here
INDV vs GHSI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, GHSI has a market cap of 4.2M. Regarding current trading prices, INDV is priced at $34.88, while GHSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas GHSI's P/E ratio is -0.79. In terms of profitability, INDV's ROE is -1.42%, compared to GHSI's ROE of +0.01%. Regarding short-term risk, INDV is more volatile compared to GHSI. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check GHSI's competition here
INDV vs RDHL Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, RDHL has a market cap of 3.1M. Regarding current trading prices, INDV is priced at $34.88, while RDHL trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas RDHL's P/E ratio is N/A. In terms of profitability, INDV's ROE is -1.42%, compared to RDHL's ROE of +2.91%. Regarding short-term risk, INDV is less volatile compared to RDHL. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check RDHL's competition here
INDV vs PLXP Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, INDV is priced at $34.88, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas PLXP's P/E ratio is -0.22. In terms of profitability, INDV's ROE is -1.42%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, INDV is less volatile compared to PLXP. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check PLXP's competition here
INDV vs CPHI Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, CPHI has a market cap of 2.4M. Regarding current trading prices, INDV is priced at $34.88, while CPHI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas CPHI's P/E ratio is -1.42. In terms of profitability, INDV's ROE is -1.42%, compared to CPHI's ROE of -0.00%. Regarding short-term risk, INDV is less volatile compared to CPHI. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check CPHI's competition here
INDV vs ATNX Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, INDV is priced at $34.88, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas ATNX's P/E ratio is -0.02. In terms of profitability, INDV's ROE is -1.42%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, INDV is more volatile compared to ATNX. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.Check ATNX's competition here
INDV vs SNOA Comparison June 2026
INDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV stands at 4.4B. In comparison, SNOA has a market cap of 2.1M. Regarding current trading prices, INDV is priced at $34.88, while SNOA trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV currently has a P/E ratio of 17.89, whereas SNOA's P/E ratio is -0.61. In terms of profitability, INDV's ROE is -1.42%, compared to SNOA's ROE of -0.86%. Regarding short-term risk, INDV is less volatile compared to SNOA. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.Check SNOA's competition here